C
Cannara Biotech Inc
XTSX:LOVE
Cannara Biotech Inc
XTSX:LOVE
Price:
1.87
CAD
1.63%
Market Closed
Market Cap:
CA$179.1m
Income Statement
Earnings Waterfall
Cannara Biotech Inc
Cannara Biotech Inc
Income Statement
Cannara Biotech Inc
Cannara Biotech Inc
Currency: CAD
| Aug-2020 | Nov-2020 | Feb-2021 | May-2021 | Aug-2021 | Nov-2021 | Feb-2022 | May-2022 | Aug-2022 | Nov-2022 | Feb-2023 | May-2023 | Aug-2023 | Nov-2023 | Feb-2024 | May-2024 | Aug-2024 | Nov-2024 | Feb-2025 | May-2025 | Aug-2025 | Nov-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||
| Interest Expense |
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
3
|
4
|
4
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
4
|
4
|
3
|
|
| Revenue |
3
N/A
|
3
+32%
|
5
+47%
|
11
+128%
|
17
+51%
|
22
+30%
|
28
+23%
|
31
+11%
|
36
+18%
|
40
+10%
|
45
+14%
|
51
+13%
|
58
+12%
|
67
+16%
|
73
+10%
|
77
+5%
|
82
+7%
|
88
+7%
|
95
+8%
|
102
+8%
|
107
+5%
|
112
+5%
|
|
| Gross Profit | |||||||||||||||||||||||
| Cost of Revenue |
(1)
|
(2)
|
(3)
|
(8)
|
(13)
|
(17)
|
(22)
|
(25)
|
(30)
|
(33)
|
(39)
|
(45)
|
(51)
|
(61)
|
(66)
|
(71)
|
(78)
|
(81)
|
(85)
|
(88)
|
(90)
|
(92)
|
|
| Gross Profit |
2
N/A
|
1
-12%
|
2
+26%
|
3
+73%
|
5
+43%
|
5
+19%
|
6
+10%
|
5
-9%
|
6
+17%
|
7
+14%
|
6
-18%
|
7
+11%
|
6
-2%
|
6
-5%
|
7
+21%
|
6
-20%
|
5
-21%
|
7
+46%
|
9
+39%
|
14
+52%
|
18
+23%
|
20
+14%
|
|
| Operating Income | |||||||||||||||||||||||
| Operating Expenses |
(13)
|
(13)
|
(11)
|
(10)
|
(10)
|
(10)
|
(11)
|
(12)
|
(12)
|
(14)
|
(14)
|
(15)
|
(16)
|
(17)
|
(19)
|
(20)
|
(22)
|
(23)
|
(23)
|
(24)
|
(25)
|
(28)
|
|
| Selling, General & Administrative |
(9)
|
(8)
|
(7)
|
(7)
|
(7)
|
(8)
|
(9)
|
(10)
|
(10)
|
(11)
|
(11)
|
(13)
|
(14)
|
(15)
|
(17)
|
(18)
|
(20)
|
(21)
|
(21)
|
(22)
|
(23)
|
(26)
|
|
| Research & Development |
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Depreciation & Amortization |
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(12)
N/A
|
(11)
+3%
|
(9)
+17%
|
(7)
+23%
|
(6)
+20%
|
(5)
+16%
|
(5)
-9%
|
(7)
-30%
|
(6)
+8%
|
(6)
-3%
|
(8)
-23%
|
(8)
-6%
|
(9)
-9%
|
(11)
-16%
|
(12)
-12%
|
(14)
-22%
|
(18)
-22%
|
(17)
+6%
|
(14)
+16%
|
(10)
+31%
|
(8)
+18%
|
(8)
0%
|
|
| Pre-Tax Income | |||||||||||||||||||||||
| Interest Income Expense |
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(5)
|
(4)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(4)
|
(4)
|
(4)
|
(3)
|
|
| Non-Reccuring Items |
(0)
|
(1)
|
(0)
|
2
|
6
|
8
|
9
|
9
|
11
|
12
|
15
|
18
|
21
|
25
|
23
|
25
|
28
|
27
|
33
|
32
|
30
|
29
|
|
| Total Other Income |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(13)
N/A
|
(14)
-4%
|
(11)
+21%
|
(7)
+39%
|
(2)
+77%
|
1
N/A
|
1
-20%
|
1
-23%
|
2
+161%
|
3
+23%
|
3
+19%
|
5
+45%
|
7
+43%
|
9
+30%
|
6
-31%
|
5
-15%
|
4
-16%
|
5
+21%
|
14
+151%
|
17
+28%
|
18
+4%
|
17
-5%
|
|
| Net Income | |||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
(0)
|
(2)
|
(5)
|
(5)
|
|
| Income from Continuing Operations |
(13)
|
(14)
|
(11)
|
(7)
|
(2)
|
1
|
1
|
1
|
2
|
3
|
3
|
5
|
7
|
9
|
6
|
5
|
6
|
7
|
13
|
16
|
13
|
12
|
|
| Income to Minority Interest |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(12)
N/A
|
(13)
-6%
|
(11)
+20%
|
(7)
+38%
|
(2)
+77%
|
1
N/A
|
1
-20%
|
1
-23%
|
2
+161%
|
3
+23%
|
3
+19%
|
5
+45%
|
7
+43%
|
9
+30%
|
6
-31%
|
5
-15%
|
6
+21%
|
7
+3%
|
13
+102%
|
16
+16%
|
13
-16%
|
12
-10%
|
|
| EPS (Diluted) |
-0.18
N/A
|
-0.02
+89%
|
-0.01
+50%
|
-0.01
N/A
|
-0.02
-100%
|
0
N/A
|
0.01
N/A
|
0
N/A
|
0.03
N/A
|
0.03
N/A
|
0.04
+33%
|
0.06
+50%
|
0.08
+33%
|
0.1
+25%
|
0.07
-30%
|
0.06
-14%
|
0.07
+17%
|
0.07
N/A
|
0.15
+114%
|
0.17
+13%
|
0.14
-18%
|
0.13
-7%
|
|
Switch to:
Switch to:
See Also
Discover More
